• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

370
60
44
42
20

COUNTRY

41
9
5
5
4

PRICE

136
413
513
1,035

PUBLISHED

24
68
291
1,035

PRODUCT TYPE

1,002
17
11
4
1

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

Alcohol Addiction - Pipeline Review, H2 2013

Alcohol Addiction - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Alcohol Addiction - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

October 2013
FROM

Rheumatoid Arthritis Pain - Pipeline Review, H2 2013

Rheumatoid Arthritis Pain - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Rheumatoid Arthritis Pain - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Other Central Nervous System Disorders - Pipeline Review, H2 2013

Other Central Nervous System Disorders - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Other Central Nervous System Disorders - Pipeline Review, H2 2013', provides an overview of the...

October 2013
FROM

Ischemic Stroke - Pipeline Review, H2 2013

Ischemic Stroke - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ischemic Stroke - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

October 2013
FROM

Partial Seizure - Pipeline Review, H2 2013

Partial Seizure - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Partial Seizure - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

October 2013
FROM

Memory Impairment - Pipeline Review, H2 2013

Memory Impairment - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Memory Impairment - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

October 2013
FROM

Traumatic Brain Injury - Pipeline Review, H2 2013

Traumatic Brain Injury - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Traumatic Brain Injury - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Sedation - Pipeline Review, H2 2013

Sedation - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Sedation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

October 2013
FROM

Psychiatric Disorders - Pipeline Review, H2 2013

Psychiatric Disorders - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Psychiatric Disorders - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Neuropathy - Pipeline Review, H2 2013

Neuropathy - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Neuropathy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Acute Spinal Cord Injury - Pipeline Review, H2 2013

Acute Spinal Cord Injury - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Acute Spinal Cord Injury - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Depression - Pipeline Review, H2 2013

Depression - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Depression - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Friedreich Ataxia - Pipeline Review, H2 2013

Friedreich Ataxia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Friedreich Ataxia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

October 2013
FROM

Mild Cognitive Impairment - Pipeline Review, H2 2013

Mild Cognitive Impairment - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Mild Cognitive Impairment - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2013

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2013', provides an overview of the indication’s...

October 2013
FROM

Chronic Pain - Pipeline Review, H2 2013

Chronic Pain - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Chronic Pain - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Anesthetic Effect - Pipeline Review, H2 2013

Anesthetic Effect - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Anesthetic Effect - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

October 2013
FROM
Frontiers in Clinical Drug Research - Central Nervous System: Volume 1 Frontiers in Clinical Drug Research - Central Nervous System: Volume 1 - Product Thumbnail Image

Frontiers in Clinical Drug Research - Central Nervous System: Volume 1

Frontiers in Clinical Drug Research – Central Nervous System presents the latest researches and clinical studies on the central nervous system (CNS) It covers a range of topics such as the development...

October 2013

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 2

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is an ebook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for...

October 2013

EpiCast Report: Autism Spectrum Disorders - Epidemiology Forecast to 2022

EpiCast Report: Autism Spectrum Disorders - Epidemiology Forecast to 2022 Summary Autism Spectrum Disorders (ASD) is a group of incurable, developmental disabilities which affect the brain and are...

October 2013
FROM
Loading Indicator

Our Clients

Our clients' logos